chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Minor patient taken by her mother for a routine family medicine visit. Patient was seen by herself without mother present. Physician was told by patient that mother was in the lobby. Physician then counseled patient to receive HPV and influenza vaccine. Patient at this time had signs of illness (cold, congested and runny nose). Vaccine information sheet for both vaccines not given to patient. Patient not asked about allergies or medical condition. Consent for flu vaccine not obtained from mother. Mother left in the lobby for the whole time without being brought back to have discussion with anyone about flu vaccine nor to be given VIS. Patient agreed to vaccines at physician recommendations. Was given both vaccines in different deltoids. After administration, patient was sent out to the waiting room immediately and not monitored for 15 minutes as recommended for HPV vaccines (due to the potential for unconciousness etc.). She was there was less than 10 minutes and then promptly had a partial seizure in mother's arms. Patient was eased to the floor where she was unconscious and nonresponsive for between 1-2 minutes. Patient awoke and was slowly oriented but experiencing weakness, dizziness, headaches, neck pain, memory loss and nausea. Memory loss has improved. Patient still weak, dizzy, with neck pain and overall body pain as of 10/19/2017.
Patient came to ED with low blood pressure and lethargy.  Patient admitted to hospital with Covid pneumonia and treated with remdesivir.
< 2 min after vaccine administration patient felt flushed & nauseated. Monitored pt. for 5 min & mother wanted to take her to ER. Pt. ended up w/ a low grade fever.
Patient was given the Pfizer Covid Bivalent vaccine but had not started the initial series of Covid vaccines. This is the only vaccine he has received. Patient had no reported reaction to vaccine. It is unclear on CDC website whether patient should receive any further Covid vaccines.
This spontaneous report was received from a licensed practical nurse and refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB injection, lot numbers L045117, expiry date 06-OCT-2018 and M001578, expiry date 21-NOV-2018 (dose and route were not reported). Additionally, it was reported that improperly stored doses of PEDIARIX (reported as "PEDIRIX"), (lot number, dose, route and frequency were not reported), were also administered. Concomitant therapies were not provided. According to the reporter, the vaccines were stored at a temperature of 13.1 degrees Celsius for 1 hour and 16 minutes. There was no previous temperature excursion reported. No adverse effect was reported. No product quality complain (PQC) was involved. It was reported that the vaccine GARDASIL 9 was also improperly stored, however, it was not administered to patients. This is one of several reports received from the same reporter. Additional information has been requested.
Non-erythematous, firm, raised, non-tender dome-like area about 10cm in diameter at the site of injection. No previous adverse reaction to DTAP (this was #4).
2-week delayed reaction of extreme chiills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (2-week delayed reaction of extreme chiills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (2-week delayed reaction of extreme chiills). At the time of the report, CHILLS (2-week delayed reaction of extreme chiills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Patient was breastfeeding her 4 month old infant.  After receiving her Covid-19 vaccine #1 she reports that her infant began havingpinkish stool with blood streaks.  Patient showed photos which I copied onto my phone.  The patient contacted her baby's pediatrician as well as the local Health Department.  Her pediatrician recommended that she go on a dairy free diet for the next 72 hours.  That afternoon on 5/20/2021 the patient defrosted breast milk saved prior to receiving her vaccine.  She fed her baby breastmilk from this thawed milk until midnight that day.  She reports that her baby's stool turned yellowwith less blood streaking.and by morning all blood streaks were gone.  72 hours later she resumed her regular diet with dairy products and there were no blood streaks noted in her baby's stool thereafter.
his hearing is gone in one ear/can't hear; narcolepsy has intensified by a thousand percent/sleepy; has Kearns syndrome and the vaccine has made his eye fall more; has Kearns syndrome and the vaccine has made his eye fall more; This is a spontaneous report from a contactable consumer (patient's wife). A 54-year-old male patient (reporter's husband) received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 2021 (lot number was not reported) as dose 1, single for COVID-19 immunization.  Medical history included ongoing Kearns syndrome and ongoing narcolepsy both from unknown dates. The patient's concomitant medications were not reported. The patient was reported to be having severe side effects from the shot on unknown dates in 2021. The patient is a dentist and since he got the vaccine, his eye has fallen more, his hearing is gone in one ear, and his narcolepsy has intensified by a thousand percent. The reporter clarified that the patient has Kearns syndrome and the vaccine has made his eye fall more. He has been home for 3 weeks. The reporter stated that she should have already filed a claim with Pfizer's safety department. This is the reporter's fifth time calling. Someone keeps calling her and she keeps calling back and leaving a message but she doesn't hear back. The reporter stated that the patient cannot work unless he has his second shot. She wanted to know if her husband should take a chance on getting his second shot of the COVID vaccine after having that experience. The patient can't hear and that's why he can't be on the phone. It's frustrating for him. The patient was losing a guaranteed salary because he can't work. The patient can no longer work and if he can't drive back, the patient's wife (reporter) is going to have to go pick him up if he's too sleepy. The reporter wanted to know if the events will eventually go away. The outcome of the events was unknown.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow-up.
Fever, Chills, severe headache like never felt before, has lasted two days so far.  Diarrhea.
he was still feeling sick; he was still feeling sick; lethargic; cant sleep night; has a sense of feeling of a warm oil running through his veins; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date at unknown, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, he got the Pfizer vaccine 3 weeks ago tomorrow and he was still feeling sick, lethargic, could not sleep night, and has a sense of feeling of a warm oil running through his veins. Reporter explained the vaccine was for COVID. Also reported that his cousin had a severe side effect, Cousin was sick with it for 2 days. Declined to complete a report for his cousin. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Expired Havrix administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 41-year-old male patient who received HAV (Havrix 1440) (batch number H4H53, expiry date 30-JAN-2023) for prophylaxis.   On 14-FEB-2023, the patient received the 2nd dose of Havrix 1440. On 14-FEB-2023, an unknown time after receiving Havrix 1440, the patient experienced expired vaccine used (Verbatim: Expired Havrix administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 9-Mar-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via postal. The patient received an expired dose of Havrix, which led to expired vaccine used.
After first dose arm pain two days late stomach ache severe nausea pains in joints stiff neck fever 100.6 teeth chattering chills and the worst headache of my life thought my head would explode Dr told me to take tylenol went to bed under covers the next day fatigue which has lingered throughout and frequent stomach and abdominal pains. reluctant to take second dose but drs convinced me since i care for the elderly after another negative covid test i went for second dose arm pain severe fatigue still experiencing stomach issues on May 1,2021 severe stomach issues slight headache extreme fatigue the next night i had trouble walking and couldn't bend my knee no sleep excrutiating pain in joints right hand swollen and lacking in movement severe abdominal issues went to hospital emergency room RA crisis bones bad
Vaccine was given to me in left arm Friday afternoon, Nov. 23. I Immediately felt itching at injection site which went away after about 10 minutes.  Later in evening and next two days, I had stomach upset (diarrhea).  Also, the next morning, I awakened with a headache and developed pain in back and muscles all over body as well as low grade fever in the evening (with chills). Fever and chills gone after one day, but even today (3rd day), I still don't feel completely "well".
COVID POSITIVE 10/23/2020.  MILD SYMPTOMS.  TESTED WEEKLY AT WORK.  LOSS OF TASTE NEXT DAY WITH EYE IRRITATION. COVID ANTIBODY TESTING ALL NEGATIVE: 4/30/20, 6/17/20, 11/18/2020, 12/22/2020, 4/1/2021  MODERNA VACCINE DOSE NUMBER 1: 3/13/2021 MODERNA VACCINE DOSE NUMBER 2: 4/10/2021 1:15PM  4/10/2021 9PM: INTENSE NAUSEA WITHOUT VOMITING.  RIGHT ARM PAIN INCREASING WITH LOWER BACK PAIN. ROPINEROL IN EVENING 0.5MG X 2 4/11/2021 ALL DAY: SLEPT MOST OF DAY, FATIGUE, SOME NAUSEA, LOW BACK PAIN WORSE, OVER ALL FATIGUE. PLACED LIDOCAINE 3% PATCH ON LOWER BACK WHICH HELPED WITH LOW BACK PAIN.  CONTINUE TO WITH OTHER BONE PAIN, FATIGUE, RIGHT ARM PAIN. 4/12/2021:  SAME AS PREVIOUS DAY. 4/12/2021:  5PM, FATIGUE RESOLVED, BACK PAIN COMPLETELY RESOLVED.    TOOK ROPINEROL IN EVENING 1MG 4/12/2021: Monday:  I took Ropineral 0.5mg at 5:30pm.  The RLS symptoms were worse, and incredibly intense.  This is the worst it has ever been.    ------------   BODY CHANGES: RLS worsened more than I've ever had experienced.  I carry the genetic variables connected to AMLD/RLD.  Symptoms usually worsen mildly 30 minutes after taking Ropineral 0.5mg.  I will usually wait for this augmentation, then 2 hours later i will take a second dose or ropineral.  The RLS was in my hips, thighs, legs.  (normally they are in the lower extremities).  This felt out of control where I wasn't able to sit at all.  my lower extremities felt like I was having vascular changes, almost a tingling, decrease blood flow.  No pain.  I wear compression knee highs while working. The RLS continues through the night until around 11:30pm.  First dose aroun 6pm.  Second dose usually around 9pm.  the RLS got progressively worse with each ropinerol I took.  RLS symptoms with decreased sleep have progressively gotten worse with each day.  Starts after taking the first ropinirole dose.  Then worsens after taking second dose.  It makes it nearly impossible to sleep.  I have never experienced th worsening of these symptoms of this.  a dramatic difference.  Ropinerol is now making it worse, but I can''t sleep without it.
Tingling in Right Arm; swelling of feet, hands and joints, hip pain and shoulder
Suspected vaccination failure/Got the vaccine, then got the worst case of shingles; Got the worst case of shingles imaginable; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 22-Aug-2022 Reporter's comment: This case was received from the patient's children via interactive digital media. The patient never had shingles, she got the vaccine and then got the worst case of shingles imaginable. The reporter said that stay away from the vaccine. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Varicella vaccine administered.  5-7 minutes after, pt had diffuse erythema including face and chest with swelling around eyes.  Pt given 0.15mg 1:10.000 epinpherine IM, pt given 7mL Benadryl solution, pt prescribed 2mg/kg/dn Prednisolone blood pressure.  Respiratory status normal throughout.  Recovered symptoms 15 minutes.  Discharged after 2 hours.
Bell's palsy right side from June 4 and continuing. Beaver of 102.1 June 4 for approximately 12 hours, headache continuing from June 3,
patient with onset of body aches, rash and diarrhea. Patient called 911, and given diphenhydrmine injection in ambulance which resulting in resolution of rash by the time patient arrived at the ED
around 5 minutes after vaccination patient fainted in our waiting area. The patient wife and myself we held the patient and laid him down  on the floor and elevated his feet. patient woke up a couple minutes later. we called 911 by the time 911 showed up patient got better and left with her wife.
Extremely itchy rash on back  that keeps spreading across my back (Rash moving across my back; Extremely sore arm at injection site; Fever; Chills; Nausea; Lethargy; This case was reported by a consumer and described the occurrence of itchy rash in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (in 1971). Previously administered products included Shingles vaccine with an associated reaction of injection site pain (received 1st dose in September 2022, refer link case US2023AMR001909). Concurrent medical conditions included hypothyroidism. Concomitant products included levothyroxine.   On 29th December 2022, the patient received the 2nd dose of Shingrix. On 1st January 2023, 3 days after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the patient experienced injection site pain, fever, chills, nausea and lethargy. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the itchy rash was not recovered/not resolved and the outcome of the injection site pain, fever, chills, nausea and lethargy were recovered/resolved.   It was unknown if the reporter considered the itchy rash, injection site pain, fever, chills, nausea and lethargy to be related to Shingrix.     Linked case(s) involving the same patient:  US2023AMR001909   Additional Information: GSK receipt date: 06-JAN-2023 Reporter's comment:  The patient self-reported this case. The patient experienced rash moving across her back starting approximately on 1st January 2023, 3 days after vaccine was given. She had an extremely sore arm at injection site, fever, chills, nausea and lethargy for 24 hours.  The patient had similar but milder symptoms as first shot.  Except for this extremely itchy rash that kept spreading across her back. The symptoms were not treated. The reporter was consented to follow up via email.; Sender's Comments:  US-GSK-US2023AMR001909:Same reporter
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 11-APR-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (injection, lot # L044058, expiration date 02-MAY-2017) (dose and route were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 9.9 degrees Fahrenheit for 163 hours and 30 minutes. There was no previous temperature excursion reported. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Fatigue,  nausea vomiting,  muscle pain joint pain, headache,  stuffy nose
Headàche, fever of 101.3, tired, chills, body aches, loss of appetite and mild nausea. Took fever reducer and slept a lot. Still experiencing all symptoms 30 hours later
started have severe burning,; after 4 days my thighs became weakened; aching pain unrelenting and spread to my upper arms after that for weeks without relief.; This is a spontaneous report from a contactable consumer (patient herself). A 75-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6200; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 16Feb2021 13:30 (at the age of 75-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included coronary artery disease, type 2 diabetes mellitus, chronic kidney disease, glaucoma, rubber sensitivity; 21 on a list, including Latex from an unknown date and unknown if ongoing. Other medications (concomitant medications) in two weeks was reported as yes (drugs not specified). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that after 4 days on 20Feb2021 11:00 patient's thighs became weakened and started have severe burning, aching pain unrelenting and spread to her upper arms after that for weeks without relief. AEs resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AEs as patient received treatment with Gabapentin 300 x 3x a day. The patient underwent lab tests and procedures which included SARS-COV-2 test (Nasal Swab) which was negative on 14Aug2021 post the vaccination. The outcome of all events was resolved with sequel on an unspecified date in 2021.  Follow-Up (29Sep2021): Follow-up attempts are completed. No further information is expected.
Immediate injection site soreness, dissipated after a few hours by moving arm after injection Fever (100.5 degrees F), chills, body aches, headache began about 8 hours after receiving the vaccine and lasted for 12 hours after that Lethargy and headache remained for additional 12-24 hours Symptoms managed with 2 Tylenol rapid release gels, 500mg each; taken first night before bed and the following morning
Red, swollen arm down to elbow, fever, chills,(for both shots) very tired and sleepy most of the time.  Bad several days, better each day thereafter except for tiredness and sleepiness.
Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Pt seen at Corporate Health Center on 9-15-09 for a post office exam. Received MMR and Td Vaccines in R arm. Sometime after developed pain in L arm and went to Danbury Hospital ED for treatment.
BODY ACHE; HEART RATE HIGH; Feeling hot; LOW GRADE FEVER; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient experienced drug allergy when treated with amoxicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body ache. On 09-APR-2021, the subject experienced heart rate high. On 09-APR-2021, the subject experienced feeling hot. On 09-APR-2021, the subject experienced low grade fever. On 09-APR-2021, the subject experienced nausea. On 09-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart rate high, and feeling hot on 10-APR-2021, was recovering from low grade fever, nausea, and body ache, and had not recovered from headache. This report was non-serious.
erythematous maculopapular rash chest/abd.  face.   arthritis (R) wrist +(L) MCP jt #1